Cancer BiologybioRxivPreprint
Development and Optimization of 111In-Dinutuximab-IRDye800, a Dual-Modality Intraoperative Molecular Imaging Agent for Pediatric Neuroblastoma Resection
Catherine Yip, Lauren Taylor Rosenblum, Arjun Pant…·Marcus M. Malek
This paper develops and optimizes 111In-Dinutuximab-IRDye800, a dual-modality imaging agent for neuroblastoma resection, finding that an optimal dose and ratio maximize tumor detection.
DOI 10.64898/2026.08.28.747876